The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Expression of Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 in Human Atherosclerotic Lesions
Abstract
Background —Oxidized LDL (Ox-LDL) seems to play key roles in atherogenesis. Lectinlike Ox-LDL receptor-1 (LOX-1) is a recently identified cell-surface receptor for Ox-LDL. The relationship of this novel receptor for Ox-LDL to atherogenesis, however, has not yet been clarified. In this study, we explored the expression of LOX-1 in the atherosclerotic lesions of human carotid arteries. Methods and Results —Using carotid endarterectomy specimens obtained from 21 patients and 2 samples of normal human aortas, we examined LOX-1 expression by reverse transcription–polymerase chain reaction and immunohistochemistry. In aortas without atherosclerosis, LOX-1 expression was undetectable by immunohistochemistry and negligible by reverse transcription–polymerase chain reaction. In carotid arteries, luminal endothelial cells covering early atherosclerotic lesions were more frequently positive for LOX-1 expression than those in advanced atherosclerotic lesions. Endothelial cells in the intimal neovasculature of advanced lesions also expressed LOX-1. In addition, macrophages and smooth muscle cells in the intima of advanced atherosclerotic plaques were positive for LOX-1 expression. Conclusions —LOX-1 may play important roles in Ox-LDL uptake and subsequent functional alteration in the luminal endothelium in early atherosclerotic lesions and in intimal neovascular endothelial cells in advanced plaques. Furthermore, LOX-1 may also be involved in Ox-LDL uptake and subsequent foam cell transformation in macrophages and smooth muscle cells in the atherosclerotic intima.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
An endothelial receptor for oxidized low-density lipoprotein
Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, T., et al. (1997) · Nature · doi:10.1038/386073a0 · Cited by 1,385
Self-citationCD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,041
Ponte, P., Ng, S.-Y., Engel, J., Gunning, P., & Kedes, L. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.3.1687 · Cited by 936
Barger, A. C., Beeuwkes, R., Lainey, L. L., & Silverman, K. J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100307 · Cited by 849
Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
Acton, S. L., Scherer, P. E., Lodish, H. F., & Krieger, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31921-x · Cited by 821
Savill, J., Hogg, N., Ren, Y., & Haslett, C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116019 · Cited by 813
Cited by
LOX-1, OxLDL, and Atherosclerosis
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 769
Mechanisms of foam cell formation in atherosclerosis
Chistiakov, D. A., Melnichenko, A. A., Myasoedova, V. A., Grechko, A. V., & Orekhov, A. N. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1575-8 · Cited by 742
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562
Macrophage‐mediated cholesterol handling in atherosclerosis
Chistiakov, D. A., Bobryshev, Y. V., & Orekhov, A. N. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12689 · Cited by 510
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Levitan, I., Volkov, S., & Subbaiah, P. V. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2733 · Cited by 473
MEHTA, J., CHEN, J., HERMONAT, P., ROMEO, F., & NOVELLI, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.09.006 · Cited by 440
Chen, M., Masaki, T., & Sawamura, T. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00236-x · Cited by 375
Self-citationFoam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
Maguire, E. M., Pearce, S. W. A., & Xiao, Q. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.08.002 · Cited by 366
Shimaoka, T., Kume, N., Minami, M., Hayashida, K., Kataoka, H., Kita, T., & Yonehara, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000761200 · Cited by 333
Self-citationBiochemistry and cell biology of mammalian scavenger receptors
Murphy, J. E., Tedbury, P. R., Homer-Vanniasinkam, S., Walker, J. H., & Ponnambalam, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.036 · Cited by 333
Macrophage scavenger receptors and host-derived ligands
Plüddemann, A., Neyen, C., & Gordon, S. (2007) · Methods · doi:10.1016/j.ymeth.2007.06.004 · Cited by 327
Macrophage Differentiation to Foam Cells
Shashkin, P., Dragulev, B., & Ley, K. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054865064 · Cited by 295
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
Xu, S., Ogura, S., Chen, J., Little, P. J., Moss, J., & Liu, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1194-z · Cited by 293
Role of Oxidized LDL in Atherosclerosis
KITA, T., KUME, N., MINAMI, M., HAYASHIDA, K., MURAYAMA, T., SANO, H., MORIWAKI, H., KATAOKA, H., NISHI, E., HORIUCHI, H., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03941.x · Cited by 277
Self-citationGreaves, D. R., & Gordon, S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400011-jlr200 · Cited by 211
Lu, J., Yang, J.-H., Burns, A. R., Chen, H.-H., Tang, D., Walterscheid, J. P., Suzuki, S., Yang, C.-Y., Sawamura, T., & Chen, C.-H. (2009) · Circulation Research · doi:10.1161/circresaha.108.190116 · Cited by 137
Self-citationSugimoto, K., Ishibashi, T., Sawamura, T., Inoue, N., Kamioka, M., Uekita, H., Ohkawara, H., Sakamoto, T., Sakamoto, N., Okamoto, Y., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp177 · Cited by 124
Self-citationHofmann, A., Brunssen, C., & Morawietz, H. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.10.002 · Cited by 68
Holven, K. B., Scholz, H., Halvorsen, B., Aukrust, P., Ose, L., & Nenseter, M. S. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3588 · Cited by 42
Robichaux, W. G., Mei, F. C., Yang, W., Wang, H., Sun, H., Zhou, Z., Milewicz, D. M., Teng, B.-B., & Cheng, X. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.314238 · Cited by 37
Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men
Dawson, K., Zhao, L., Adkins, Y., Vemuri, M., Rodriguez, R. L., Gregg, J. P., Kelley, D. S., & Hwang, D. H. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.004 · Cited by 24
Metadata
- Authors
- Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Moriwaki, H., Murase, T., Sawamura, T., Masaki, T., Hashimoto, N., & Kita, T.
- Venue
- Circulation
- Published
- 1999-06-22
- Volume
- 99
- Issue
- 24
- Pages
- 3110-3117
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2043199161
- Cited by
- 443
- References
- 42
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.